Subsequently, we also evaluated resting CD8+ T lymphocytes, which were shown to lose the ability to reach tumor mass in microenvironments conditioned by certain tumors, such as triple negative breast cancer [34]. This evidence concerns the gene CD8A and triple-negative breast carcinoma.